Condition: Heart Failure · Sponsor: Niguarda Hospital
The purpose of this study is to better understand the time course of different biological mechanisms involved in acute decompensated heart failure complicated by cardiogenic shock throughout the evaluation of changes and the relationship among markers of inflammation (IL-6) and markers of increased endothelial permeability (Ang-2) or endothelial glycocalyx perturbation (Syndecan-1 and HS) and throughout a targeted metabolomic approach.
This description comes directly from the study's public registry record.
Nuccia Morici, MD · +39026444 · nuccia.morici@ospedaleniguarda.it
Alice Sacco, MD · +39026444 · alice.sacco@ospedaleniguarda.it
Always discuss trial participation with your own doctor first.
| Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda | Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04323371